First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study
Viktoria Hermann, Anastas Batalov, Svetlana Smakotina, Pierre-Eric Juif, Peter Cornelisse
Lupus Science & Medicine Oct 2019, 6 (1) e000354; DOI: 10.1136/lupus-2019-000354